Newer forms of birth control pills can reduce risk of ovarian cancer, says study

Chances of ovarian cancer can be reduced even by the newer forms of birth control pills, suggested a recent study.

Sreemoyee Chatterjee | Published: September 28, 2018 6:00 pm

Newer forms of birth control pills can reduce chances of ovarian cancer © Shutterstock

The latest form of birth control pills can reduce risk of ovarian cancer just like the older forms of pills, suggested a recent research. According to the scientists, the protective effect of the newer pills containing lower doses of oestrogens and different progestogens increased over time and remained for several years even after the women stopped popping them. The study was conducted by a team of researchers at the University of Aberdeen in Scotland.

Dr Lisa Iversen, the research lead, reportedly said: “Based on our results, contemporary combined hormonal contraceptives are still associated with a reduced risk of ovarian cancer in women of reproductive age.” While the study was not able to prove cause and effect, the researchers highlighted prior research that showed that women taking the older forms of oral contraceptives were likely to have a lower risk for ovarian cancer.

In order to find out if newer hormonal contraceptives with combined hormones and progestogen-only products also had the same link with ovarian cancer, the team of researchers tracked data on nearly 1.9 million Danish women belonging to the age bracket of 15 to 49, highlighted a recent media report.

The same report revealed that these women were split into group of three. One group included those women who never used hormonal birth control pills, the second had those who use them at present or used them recently for up to one year and the third group had former users who took pills for over a year.

The study was published in the BMJ and showed that 86% of the women took combined birth control pills along with indicating that the use of these pills prevented 21% of ovarian cancers among these women.

Published: September 28, 2018 6:00 pm

Disclaimer: TheHealthSite.com does not guarantee any specific results as a result of the procedures mentioned here and the results may vary from person to person. The topics in these pages including text, graphics, videos and other material contained on this website are for informational purposes only and not to be substituted for professional medical advice.

FDA approves of a new class of medications for treating migraine

This new antibiotic will restrict multi-drug resistance, shows study

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

India Webportal Private Limited 135, Continental Building, Dr. Annie Basent Road, Worli, Mumbai – 400 018.

Email Subscription

Enter your email id to get latest updates and latest news about health.

We respect your privacy

FDA approves of a new class of medications for treating migraine

This new antibiotic will restrict multi-drug resistance, shows study

About The health Site

Useful Links

Email Subscription